(Q44807317)

English

Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy

scientific article published on 4 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Guiming Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jin Peng

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Weiguo Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Guangzhou Tao

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yaqi Song

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Xilei Zhou

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Wanwei Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

4 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

263

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

https://scigraph.springernature.com/pub.10.1007/s12032-014-0263-6

0 references

Treatment options for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Neoadjuvant treatment for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Molecular aspects of esophageal squamous cell carcinoma carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Development of microRNA therapeutics is coming of age.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MicroRNA and diseases: therapeutic potential as new generation of drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Different expression of miRNAs in early esophageal squamous cell carcinoma with differential prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Comment on 'TAp63 suppress metastasis via miR-133b in colon cancer cells'.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0263-6

21 January 2018

MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current management of esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25280517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-014-0263-6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44807317&oldid=2046846710"